VEGF-integrin interplay controls tumor growth and vascularization

被引:142
作者
De, S [1 ]
Razorenova, O [1 ]
McCabe, NP [1 ]
O'Toole, T [1 ]
Qin, J [1 ]
Byzova, TV [1 ]
机构
[1] Cleveland Clin Fdn, Joseph J Jacobs Ctr Thrombosis & Vasc Biol, Dept Mol Cardiol, Cleveland, OH 44195 USA
关键词
activation; angiogenesis; Src homology 2 domain containing;
D O I
10.1073/pnas.0502935102
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cross-talk between the major angiogenic growth factor, VEGF, and integrin cell adhesion receptors has emerged recently as a critical factor in the regulation of angiogenesis and tumor development. However, the molecular mechanisms and consequences of this intercommunication remain unclear. Here, we define a mechanism whereby integrin alpha v beta 3, through activation, clustering, and signaling by means of p66 Shc (Src homology 2 domain containing), regulates the production of VEGF in tumor cells expressing this integrin. Tumors with "activatable" but not "inactive" beta 3 integrin secrete high levels of VEGF, which in turn promotes extensive neovascularization and augments tumor growth in vivo. This stimulation of VEGF expression depends upon the ability of alpha v beta 3 integrin to cluster and promote phosphorylation of p66 Shc. These observations identify a link between 63 integrins and VEGF in tumor growth and angiogenesis and, therefore, may influence anti-integrin as well as anti-VEGF therapeutic strategies.
引用
收藏
页码:7589 / 7594
页数:6
相关论文
共 30 条
[1]   Aggregation of integrins and RhoA activation are required for Thy-1-induced morphological changes in astrocytes [J].
Avalos, AM ;
Arthur, WT ;
Schneider, P ;
Quest, AFG ;
Burridge, K ;
Leyton, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (37) :39139-39145
[2]   Fibronectin matrix regulates activation of Rho and Cdc42 GTPases and cell cycle progression [J].
Bourdoulous, S ;
Orend, G ;
MacKenna, DA ;
Pasqualini, R ;
Ruoslahti, E .
JOURNAL OF CELL BIOLOGY, 1998, 143 (01) :267-276
[3]   A mechanism for modulation of cellular responses to VEGF: Activation of the integrins [J].
Byzova, TV ;
Goldman, CK ;
Pampori, N ;
Thomas, KA ;
Bett, A ;
Shattil, SJ ;
Plow, EF .
MOLECULAR CELL, 2000, 6 (04) :851-860
[4]  
CHEN YP, 1994, BLOOD, V84, P1857
[5]   The role of αvβ3 in prostate cancer progression [J].
Cooper, CR ;
Chay, CH ;
Pienta, KJ .
NEOPLASIA, 2002, 4 (03) :191-194
[6]   Integrin signaling: Cytoskeletal complexes, MAP kinase activation, and regulation of gene expression [J].
Danen, EHJ ;
Lafrenie, RM ;
Miyamoto, S ;
Yamada, KM .
CELL ADHESION AND COMMUNICATION, 1998, 6 (2-3) :217-224
[7]   Molecular pathway for cancer metastasis to bone [J].
De, S ;
Chen, JH ;
Narizhneva, NV ;
Heston, W ;
Brainard, J ;
Sage, EH ;
Byzova, TV .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (40) :39044-39050
[8]   Vascular endothelial growth factor: Basic science and clinical progress [J].
Ferrara, N .
ENDOCRINE REVIEWS, 2004, 25 (04) :581-611
[9]   Role of angiogenesis in tumor growth and metastasis [J].
Folkman, J .
SEMINARS IN ONCOLOGY, 2002, 29 (06) :15-18
[10]  
Furger KA, 2003, MOL CANCER RES, V1, P810